Anaphylactic Shock News and Research

RSS
Anaphylactic shock or anaphylaxis is a severe and sometimes life-threatening immune system reaction to an antigen that a person has been previously exposed to. The reaction may include itchy skin, edema, collapsed blood vessels, fainting, difficulty in breathing, and death.
Wake Forest Baptist Physician offers tips to prevent bites and rashes in summer

Wake Forest Baptist Physician offers tips to prevent bites and rashes in summer

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

Research team designs new type of flour that could control food allergies without side effects

Research team designs new type of flour that could control food allergies without side effects

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Asthma drug accelerates desensitization in patients with food allergies to several foods

Asthma drug accelerates desensitization in patients with food allergies to several foods

Lone star tick bites are likely the cause of severe red meat allergies

Lone star tick bites are likely the cause of severe red meat allergies

Anaphylaxis Campaign provides updated information on Idiopathic anaphylaxis

Anaphylaxis Campaign provides updated information on Idiopathic anaphylaxis

Amneal launches generic Esomeprazole strontium delayed-release capsules 49.3 mg

Amneal launches generic Esomeprazole strontium delayed-release capsules 49.3 mg

Amneal's Esomeprazole Strontium 49.3 mg delayed-release capsules now available for GERD patients

Amneal's Esomeprazole Strontium 49.3 mg delayed-release capsules now available for GERD patients

New legislation to provide epinephrine to children with severe food allergies in schools

New legislation to provide epinephrine to children with severe food allergies in schools

EMA expands administration options for Hizentra

EMA expands administration options for Hizentra

Researchers made breakthrough development in inhibitory therapeutic for hypersensitive allergic reactions

Researchers made breakthrough development in inhibitory therapeutic for hypersensitive allergic reactions

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

Boehringer signs agreement with Brigham to conduct long-term study program on oral anticoagulants

Boehringer signs agreement with Brigham to conduct long-term study program on oral anticoagulants

Princeton University researcher explores seriousness of peanut allergy

Princeton University researcher explores seriousness of peanut allergy

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Smartphone solutions for clinical trials

Smartphone solutions for clinical trials

Study investigates use of sublingual immunotherapy against ragweed allergy

Study investigates use of sublingual immunotherapy against ragweed allergy

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

FAP cells help in repairing injured muscles

FAP cells help in repairing injured muscles